drugset / Trial / NCT03654417

Pain Perception During Vulvar Biopsy

NCT03654417 ↗

Phase 4 Terminated 37 enrolled Duke University
RandomizedParallel-groupOpen-labelSupportive care

Summary

The purpose of this study is to compare pain control during vulvar biopsy following either (1) application of EMLA (a eutectic mixture of local anesthetics lidocaine 2.5% and prilocaine 2.5%) cream or (2) injection of 1% lidocaine. We hypothesize that lidocaine will provide better biopsy analgesia, but the benefit will be offset by the pain of lidocaine injection compared to EMLA application, thus there will not be a significant difference in highest pain scores between the two groups.

Timeline

Start
2018-09-17
Primary completion
2019-03-12
Completion
2019-03-12

Outcome

Outcome not reported

Stopped (Enrollment): “interim analysis produced significant results, so we ended enrollment”

Drugs

EvaluationDrugModalityDoseRoute
Comparator EMLA Unknown 2.5 % Topical
Comparator Lidocaine Other / unclassified 1 % Other

Indications